The field of cancer mutation discovery has evolved significantly with advancements in sequencing technologies and computational methods. Early studies relied on cytogenetics and karyotyping, while modern approaches use high-throughput sequencing and sophisticated bioinformatics tools. These advancements have accelerated the pace of discovery and enhanced our understanding of cancer genetics.
